Drug intelligence / Profile preview

magnesium valproate

Development stage
Approved
Lead developer
BioLink LifeSciences
Modality
Small Molecules
Administration
Oral, Intravenous, Rectal
01

Overview

Magnesium valproate is a salt form of valproic acid, an anticonvulsant and mood-stabilizing drug. It is primarily used to treat epilepsy (both localized and generalized seizures), bipolar disorder (especially manic episodes), and for the prevention of migraine headaches. The mechanism of action involves stabilizing neuronal activity by increasing brain levels of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, through inhibition of GABA degradative enzymes such as GABA transaminase and succinate-semialdehyde dehydrogenase, as well as inhibiting GABA reuptake. Magnesium valproate also blocks voltage-gated sodium channels, contributing to its anticonvulsant effects. Additionally, it acts as a histone deacetylase inhibitor with epigenetic effects[4][6][8][10].

02

Targets

NaV (Voltage-gated sodium channels)CaV3 (Caveolin-3)HDAC (HDAC family)ABAT (4-aminobutyrate aminotransferase)

Beyond the preview

Go deeper on magnesium valproate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium valproate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call